cinchonidine has been researched along with Cardio-Renal Syndrome in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chung, CL; Hsieh, CY; Sheu, JR; Teng, RD; Yang, CH | 1 |
1 other study(ies) available for cinchonidine and Cardio-Renal Syndrome
| Article | Year |
|---|---|
Attenuation of indoxyl sulfate-induced cell damage by cinchonidine-a Cinchona alkaloid-through the downregulation of p53 signaling pathway by promoting MDM2 cytoplasmic-nuclear shuttling in endothelial cells.
Topics: Cardio-Renal Syndrome; Cinchona Alkaloids; Down-Regulation; Human Umbilical Vein Endothelial Cells; Humans; Indican; Proto-Oncogene Proteins c-mdm2; Signal Transduction; Tumor Suppressor Protein p53 | 2023 |